NCT00078689View on ClinicalTrials.gov

Daclizumab and Sirolimus to Treat Uveitis

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

March 3, 2004

Study Completion Date

July 18, 2008

Conditions

Uveitis

Interventions

DRUG

Daclizumab

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors

lead

National Eye Institute (NEI)

NIH

NCT00078689 - Daclizumab and Sirolimus to Treat Uveitis | Biotech Hunter | Biotech Hunter